Cognex Heads Into Earnings with Shorts Retreating and Options Turning Bullish
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
CGNX approaches its November 4 earnings release with an unusual dynamic: short sellers have been stepping back sharply while the options market simultaneously tilts toward calls, a combination that sets a notably optimistic tone heading into a print that has historically punished longs.
The short side has been unwinding for the past month. Shares sold short have fallen roughly 19% over 30 days to about 3.7% of the free float, a level that is noticeable but not extreme. More striking is the pace: the week alone saw a 9.8% reduction in short positions. The borrow market reflects the light positioning. Availability is exceptionally loose at around 3,116%, meaning there are more than 31 shares available to lend for every one already borrowed. Cost to borrow remains negligible at 0.49%, even after a 9% rise on the week. This is not a market under any squeeze pressure. Short sellers have been orderly exits, not forced ones, and nothing in the lending data suggests the remaining 3.7% position faces any near-term mechanical pressure.
Options positioning reinforces the bullish lean. The put/call ratio has dropped to 0.36, well below its 20-day average of 0.40, and sits close to the lower end of its 52-week range of 0.14 to 0.60. The z-score of roughly negative 0.78 indicates call demand is running modestly above the recent norm, though the setup is measured rather than euphoric. The ORTEX short score has also been drifting lower all month, from 38.2 on October 20 to 36.7 at the end of October. A lower short score means the signal tilts toward less bearish positioning, consistent with the broader picture of a market leaning constructive into the print. The combination of retreating shorts, cheap borrow, and a call-heavy options skew tells a story of incremental confidence rather than aggressive conviction.
The Street is more divided than the positioning suggests. Analyst consensus has a mean price target of about $79, roughly 41% above the current price of $56.15, but that gap reflects a fragmented picture rather than a straightforward bull case. Barclays lifted its Overweight target to $85 in mid-October. Truist Securities held its Hold rating while trimming its target to $74. Baird cut to $70 from $78 in late September while staying Neutral. The result is a consensus that contains genuine bulls alongside a cluster of neutral-to-cautious views, with the wide target spread making the mean somewhat misleading as a summary. The EV/EBITDA multiple of around 24x has been broadly flat over 30 days, and the PE of 30x has eased slightly from last month. On factor scores, earnings momentum over 90 days ranks at 75, but 30-day EPS momentum sits at just 39, suggesting the wave of estimate upgrades has already been absorbed.
The bull case rests on structural demand from automation, AI adoption, and reshoring, with management guiding to $1.130 to $1.150 billion in 2026 revenue and adjusted EPS of $1.64 to $1.68. Free cash flow of $68 million in the second quarter and $755 million of cash with no debt give the company flexibility. Bears point to the 62% revenue exposure to cyclical end markets, meaningful Greater China concentration, and competitive pressure from domestic and Asian rivals. The RealSense acquisition adds a robotics perception angle, with $80 to $90 million of projected 2026 sales, but integration execution remains an open question.
Institutional ownership provides some context on the demand backdrop. BlackRock has built the largest position at 9.5% of shares, adding nearly 297,000 shares in the quarter to September. Invesco made the most aggressive move, adding almost 4 million shares to reach 4.1% of the company. T. Rowe Price added 1.5 million shares to reach 3.7%. These are material additions from institutional buyers, and they arrived as the stock was pulling back: CGNX is down 5.9% over the past month and closed Friday at $56.15 after falling 4.8% on October 30 alone. The buying from large managers while the stock has been soft adds a layer of support to the constructive positioning narrative, but the most recent data covers the period to September 30 and may not reflect how institutions responded to the October weakness.
The earnings history offers a caution. The last print in August produced a one-day decline of about 5.4% and a five-day decline of roughly 12.9%. What to watch on November 4 is whether the combination of retreating short interest, call-heavy options, and institutional buying provides any cushion against that pattern, or whether the stock's history of post-earnings selloffs reasserts itself regardless of how positioning has shifted.
Stocks in this article
See the live data behind this article on ORTEX.
Open CGNX on ORTEX →How this article was generated
- Generated
- 31 Oct 2026, 20:08
- Data as of
- 31 Oct 2026, 20:08
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.